16-71626339-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052858.6(MARVELD3):c.110G>A(p.Arg37Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000267 in 1,548,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052858.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MARVELD3 | NM_052858.6 | c.110G>A | p.Arg37Gln | missense_variant | 1/3 | ENST00000268485.8 | |
MARVELD3 | NM_001017967.4 | c.110G>A | p.Arg37Gln | missense_variant | 1/3 | ||
MARVELD3 | NM_001271329.2 | c.110G>A | p.Arg37Gln | missense_variant | 1/3 | ||
MARVELD3 | XM_011523449.4 | c.110G>A | p.Arg37Gln | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MARVELD3 | ENST00000268485.8 | c.110G>A | p.Arg37Gln | missense_variant | 1/3 | 1 | NM_052858.6 | P2 | |
ENST00000562763.1 | n.219+259C>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152074Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000215 AC: 32AN: 148750Hom.: 0 AF XY: 0.000239 AC XY: 19AN XY: 79484
GnomAD4 exome AF: 0.000261 AC: 365AN: 1395992Hom.: 0 Cov.: 63 AF XY: 0.000267 AC XY: 184AN XY: 688506
GnomAD4 genome AF: 0.000322 AC: 49AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.000310 AC XY: 23AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 12, 2024 | The c.110G>A (p.R37Q) alteration is located in exon 1 (coding exon 1) of the MARVELD3 gene. This alteration results from a G to A substitution at nucleotide position 110, causing the arginine (R) at amino acid position 37 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at